AbbVie (ABBV)Rep. Pete Sessions (TX17) disclosed a sale $15K–$50K

$15,001–$50,000

Reported range · official band, not an exact amount

4 days

Disclosure lag

Traded

Sep 14, 2026

Disclosed

Sep 18, 2026

The story around this disclosure

Every dated public record OQRO holds about the company from 60 days before to 120 days after, oldest first. It shows what was going on; none of it is a stated reason for the trade.

1. Mar 27, 2026CongressDisclosed purchase of ABBV — reported range $15,001 - $50,000
2. Jun 18, 2026Federal contract · $4K obligatedDepartment of Defense awarded AbbVie: $3.6K obligated to date
3. Jul 1, 2026Federal contract · $3K obligatedDepartment of Defense awarded AbbVie: $3.3K obligated to date
4. Jul 31, 2026Company filing · Form 8-K · ResultsReported its results
5. Aug 14, 2026Insider · Their largest sale since 2023Officer sold ~$8.18M of ABBV shares in the open market
6. Sep 1, 2026Government · Federal Register noticeDetermination That NAMENDA (Memantine Hydrochloride) Tablets, 5 Milligrams and 10 Milligrams, Were Not Withdrawn From Sale for Reasons of Safety or Effectiveness
7. Sep 2, 2026Government · Federal Register noticeDetermination That CARAFATE (Sucralfate) Oral Suspension, 1 Gram/10 Milliliters, Was Not Withdrawn From Sale for Reasons of Safety or Effectiveness
8. Sep 14, 2026 · this disclosureCongressDisclosed sale of ABBV — reported range $15,001 - $50,000

What came next

1. Sep 25, 2026FDAFDA drug approval: Juvmo
2. Oct 5, 2026Company filing · Form 8-K · ResultsReported its results

How to read House Clerk periodic transaction report

The STOCK Act is a 2012 US law that requires members of Congress, and some senior staff, to publicly report their stock trades, and those of their spouse and dependent children, within 45 days.

Full guide: What is the STOCK Act?

What else is on file for AbbVie

For AbbVie, OQRO holds 2 insider filings (SEC Form 4 or Form 144), 2 Congress trade reports, 130 fund holdings reports (13F) and 2 federal contract awards dated in the last 90 days.

These are records OQRO holds, counted by their date, not a measure of how much trading took place. Routine paperwork such as option exercises and tax withholding is left out. Everything for the company is on its ABBV page.

Other recent filings by Rep. Pete Sessions (TX17)

• House Clerk periodic transaction report at Apple (AAPL)Sep 22, 2026
• House Clerk periodic transaction report at Alphabet (GOOGL)Sep 18, 2026
• House Clerk periodic transaction report at Ares Capital (ARCC)Jul 24, 2026
• House Clerk periodic transaction report at Verizon (VZ)Mar 9, 2026
• House Clerk periodic transaction report at Danaher Corporation (DHR)Jun 21, 2025

The full history of Rep. Pete Sessions (TX17) is on the profile page.

How this filing works

• The STOCK Act

Other disclosures at AbbVie

• SEC Form 13F-HRAug 26, 2026
• SEC Form 13F-HRAug 25, 2026
• SEC Form 4Aug 18, 2026
• SEC Form 13F-HRAug 17, 2026
• SEC Form 144Aug 14, 2026
• SEC Form 13F-HRAug 14, 2026

Everything OQRO holds on this company is on its ABBV page.